These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28590017)

  • 1. Fibrotic focus: An important parameter for accurate prediction of a high level of tumor-associated macrophage infiltration in invasive ductal carcinoma of the breast.
    Shimada H; Hasebe T; Sugiyama M; Shibasaki S; Sugitani I; Ueda S; Gotoh Y; Yasuda M; Arai E; Osaki A; Saeki T
    Pathol Int; 2017 Jul; 67(7):331-341. PubMed ID: 28590017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer.
    Miyasato Y; Shiota T; Ohnishi K; Pan C; Yano H; Horlad H; Yamamoto Y; Yamamoto-Ibusuki M; Iwase H; Takeya M; Komohara Y
    Cancer Sci; 2017 Aug; 108(8):1693-1700. PubMed ID: 28574667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jagged1 modulated tumor-associated macrophage differentiation predicts poor prognosis in patients with invasive micropapillary carcinoma of the breast.
    Liu H; Wang J; Liu Z; Wang L; Liu S; Zhang Q
    Medicine (Baltimore); 2017 Apr; 96(16):e6663. PubMed ID: 28422875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.
    Mwafy SE; El-Guindy DM
    J Egypt Natl Canc Inst; 2020 Jan; 32(1):6. PubMed ID: 32372332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical tumor-stromal fibroblasts in invasive ductal carcinoma of the breast.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
    Am J Surg Pathol; 2011 Mar; 35(3):325-36. PubMed ID: 21317705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 expression in tumor-stromal fibroblasts forming and not forming fibrotic foci in invasive ductal carcinoma of the breast.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
    Mod Pathol; 2010 May; 23(5):662-72. PubMed ID: 20208478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Important histologic outcome predictors for patients with invasive ductal carcinoma of the breast.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Kinoshita T; Tsuda H
    Am J Surg Pathol; 2011 Oct; 35(10):1484-97. PubMed ID: 21881484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of M2 macrophages at neural invasion in patients with invasive ductal carcinoma of the pancreas.
    Sugimoto M; Mitsunaga S; Yoshikawa K; Kato Y; Gotohda N; Takahashi S; Konishi M; Ikeda M; Kojima M; Ochiai A; Kaneko H
    Eur J Cancer; 2014 Jul; 50(11):1900-8. PubMed ID: 24835032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage level is not affected by monocyte chemotactic protein-1 in invasive ductal breast carcinoma.
    Valković T; Fuckar D; Stifter S; Matusan K; Hasan M; Dobrila F; Jonjić N
    J Cancer Res Clin Oncol; 2005 Jul; 131(7):453-8. PubMed ID: 15883814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma.
    Ohtaki Y; Ishii G; Nagai K; Ashimine S; Kuwata T; Hishida T; Nishimura M; Yoshida J; Takeyoshi I; Ochiai A
    J Thorac Oncol; 2010 Oct; 5(10):1507-15. PubMed ID: 20802348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grading system for blood vessel tumor emboli of invasive ductal carcinoma of the breast.
    Sugiyama M; Hasebe T; Shimada H; Takeuchi H; Shimizu K; Shimizu M; Yasuda M; Ueda S; Shigekawa T; Osaki A; Saeki T
    Hum Pathol; 2015 Jun; 46(6):906-16. PubMed ID: 25890786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast.
    Jitsuiki Y; Hasebe T; Tsuda H; Imoto S; Tsubono Y; Sasaki S; Mukai K
    Mod Pathol; 1999 May; 12(5):492-8. PubMed ID: 10349987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased circulating M2-like monocytes in patients with breast cancer.
    Zhang B; Cao M; He Y; Liu Y; Zhang G; Yang C; Du Y; Xu J; Hu J; Gao F
    Tumour Biol; 2017 Jun; 39(6):1010428317711571. PubMed ID: 28639912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrotic focus in breast carcinomas: relationship with prognostic parameters and biomarkers.
    Mujtaba SS; Ni YB; Tsang JY; Chan SK; Yamaguchi R; Tanaka M; Tan PH; Tse GM
    Ann Surg Oncol; 2013 Sep; 20(9):2842-9. PubMed ID: 23539156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer.
    He Y; Zhou S; Deng F; Zhao S; Chen W; Wang D; Chen X; Hou J; Zhang J; Zhang W; Ding L; Tang J; Zhou Z
    Aging (Albany NY); 2019 Dec; 11(23):10883-10901. PubMed ID: 31799941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus.
    Hasebe T; Mukai K; Tsuda H; Ochiai A
    Pathol Int; 2000 Apr; 50(4):263-72. PubMed ID: 10849311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma.
    Yang Z; Ni W; Cui C; Fang L; Xuan Y
    Exp Mol Pathol; 2017 Apr; 102(2):262-267. PubMed ID: 28223108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study.
    Hasebe T; Sasaki S; Imoto S; Mukai K; Yokose T; Ochiai A
    Mod Pathol; 2002 May; 15(5):502-16. PubMed ID: 12011255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High CD204+ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder.
    Wang B; Liu H; Dong X; Wu S; Zeng H; Liu Z; Wan D; Dong W; He W; Chen X; Zheng L; Huang J; Lin T
    Oncotarget; 2015 Aug; 6(24):20204-14. PubMed ID: 26001293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer.
    Raphael J; Gong IY; Nofech-Mozes S; Bartlett J; Nafisi H; Verma S
    J Clin Pathol; 2016 Jun; 69(6):552-5. PubMed ID: 26951081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.